Envoyer ce communique par e-mail
Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe
*
Marquer les champs requis
Nom du destinataire:
*
Adresse e-mail du destinataire:
Message:
*
Enter security words: